NASDAQ: PRME · Biotechnology
Over the past week, Prime Medicine (PRME) saw 15 mentions across Reddit, X and news, and the read is an Adanos Buy. The crowd averages 77% bullish but is far apart: Reddit runs 100% bullish while X sits at just 56%. Wall Street is roughly in line with the crowd, with 10 of 13 analysts rating PRME a buy.
There is little buzz around PRME this week and little agreement on direction, which is why it reads as a Buy.
Wall Street’s 77% buy share sits next to a crowd that ranges from X at 56% to Reddit at 100%. No other tracker puts the two side by side.
Across 13 analysts the consensus is a Strong Buy: 10 buy calls against 0 sell, with an average 12-month price target of $7.03.
The Adanos signal blends each source’s bullish ratio, source breadth, buzz intensity and 3-day momentum. This week bullish sits above the neutral line, momentum is improving and the 3 sources disagree sharply, so the read is a Buy.
Wall Street’s 77% buy share lands almost exactly on the crowd average of 77%. The split is inside the crowd: Reddit reads 100% bullish while X sits at 56%, a 44-point spread that single-source trackers miss.
Over the 30-day window, Prime Medicine (PRME) buzz held subdued around 27.2 while the price drifted down 1.3% across the period. The chart tracks how social and news attention moved against end-of-day price. Average daily trading volume across the displayed trading days is 2.6M shares. Updated Aug 15, 2026. Over the last 7 trading days, PRME gained 4.7%. Buzz activity in the recent week averaged 27.2 and was relatively stable, swinging between 20.8 and 31.2. Recent volume is running below the 30-day average, pointing to quieter participation. Daily crowd sentiment leaned bullish on 12 of the 17 days with directional mentions, shown as the green, grey and red breakdown bars below the chart.
Signal metrics use the latest 7 days; contributor and breadth context uses the 30-day chart window.
No Polymarket data for this stock this week.
Query sentiment for PRME and 2000+ stocks from your terminal. Filter by source, timeframe and signal strength.
View CLIEmbed live PRME sentiment on your own site with drop-in web components.
View WidgetsThis week’s sentiment from Adanos, with fundamentals and analyst consensus. A quick-reference snapshot for Aug 15, 2026.
| Adanos signal | Buy |
|---|---|
| Analyst consensus | Strong Buy (10 / 3 / 0) |
| Crowd bullish (7d) | 77% |
| Avg price target | $7.03 |
| Most bullish source | Reddit, 100% |
| Most bearish source | X, 56% |
| Sentiment spread | 44 pts |
| Mentions (7d) | 15 |
| Market cap | $560.5M |
| EPS · Beta | -$1.05 · 2.3 |
| Revenue (TTM) | $4.1M · 0% margin |
| Industry | Biotechnology |
Based on aggregated sentiment from Reddit, X and News sources, Prime Medicine (PRME) currently carries an Adanos buy signal with 93/100 conviction. The current cross-source average reads 77% bullish across 3 active sources. Those sources contribute 15 tracked mentions over the last 7 days. This is a sentiment-based reading, not financial advice.
Reddit discussion around Prime Medicine (PRME) is fairly quiet with 2 mentions over the last 7 days; the 30-day context spans 2 tracked subreddits. The 7-day tone is 100% bullish; 3-day activity momentum is stable, suggesting steady attention.
The crowd reads bullish on Prime Medicine (PRME), averaging 77% bullish across 3 tracked sources over the last 7 days. The two ends of the range are Reddit at 100% bullish and X at 56%, a 44-point spread. On the professional side, 10 of 13 analysts rate PRME a buy.
Of the 13 analysts covering Prime Medicine (PRME), 10 rate it a buy, 3 a hold and 0 a sell, for a strong buy consensus. The average price target is $7.03. That lines up with the crowd average of 77% bullish.
Prime Medicine (PRME)'s cross-source average is bullish at 77% bullish. All 3 tracked sources lean bullish. Reddit reads 100% bullish, News reads 75% bullish and x coverage is the most negative at 56% bullish. The combined signal points to broad buy-side pressure with 93/100 conviction.
The cross-source average is bullish for Prime Medicine (PRME) at 77% bullish. All 3 tracked sources lean bullish. The most bearish reading is x at 56% bullish. 3-day activity momentum is rising across X and News. The buy signal carries 93/100 conviction.
X is the dominant discussion channel with 9 mentions (60% of total volume). News contributes 4 mentions and Reddit contributes 2 mentions. The cross-source average is bullish at 77% bullish, while x and news show rising 3-day activity. All 3 tracked sources lean bullish.
The Adanos signal blends bullish ratio, buzz score, source breadth and 3-day activity momentum into a single buy/sell reading. PRME's buy signal at 93/100 conviction reflects a bullish cross-source average at 77% bullish. All 3 tracked sources lean bullish. It is a research shortcut, not financial advice.
The PRME sentiment page is regenerated from the latest 7-day tracking window at each build. Data reflects the most recent Reddit posts, tweets and news articles available in the current publishing cycle.
Peers are ranked first by matching the Buy signal, then by the closest bullish ratio. Discussion activity breaks any remaining ties.
Every data point on this page comes from the Adanos sentiment APIs. Get a free API key and start querying Reddit, X, News and Polymarket sentiment programmatically.
Get Free API Key